William Blair & Company
EVH icon

William Blair & Company’s Evolent Health EVH Stock Holding History

William Blair & Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-800
Closed -$18K – 1637
2017
Q1 		$18K Buy
+800
New +$15.4K ﹤0.01% 1385

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company's EVH Position: Q1 2026 in Review

William Blair & Company reduced its Evolent Health (EVH) stake by 19% in Q1 2026, selling an estimated $25.9K and leaving 35,039 shares worth $79.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

William Blair & Company first reported a position in EVH in Q1 2016 and has held it in 41 quarters since. The position peaked at $107M in Q1 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • William Blair & Company held 35,039 shares of Evolent Health worth $79.9K as of Q1 2026.
  • William Blair & Company sold 8,167 Evolent Health shares in Q1 2026, an estimated $25.9K.
  • Evolent Health made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1632 holding.
  • William Blair & Company first reported a position in Evolent Health in Q1 2016 and has held it in 41 quarters since.
  • William Blair & Company's Evolent Health position peaked at $107M in Q1 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.